These ten large-cap stocks were the worst performers in the last week. Are they in your wallet?
- Summit Therapeutics SMMT Shares fell 14.37% last week after Citigroup downgraded its stock from Buy to Neutral but raised its price target from $19 to $23.
- MakeMyTrip Limited MMYT Shares plummeted 12.46%.
- Medpace Holdings, Inc. MEDP Shares fell 9.37% after Jefferies downgraded the stock from Buy to Hold and lowered its price target from $415 to $345.
- Regeneron Pharmaceuticals Inc. RAIN The stock lost 8.94% last week after Leerink Partners downgraded it from Outperform to Market Perform and reduced its price target from $1,175 to $1,077.
- Global Payments Inc. GPN Shares plunged 8.74% after the company guided FY25 EPS growth below estimates, and several companies downgraded the stock and reduced their respective price targets.
- Affirm Holdings Inc. AFRM Shares lost 8.39% last week. There was no specific news from the company to justify the price loss.
- Super Micro Computer, Inc. SMCI Shares fell 8.21% following a report that the company is being investigated by the Department of Justice following a brief report in August Hindenburg Research.
- TechnipFMC plc FTI Shares fell 6.10% amid reports suggesting Saudi Arabia could increase crude oil production.
- First Citizens BancShares, Inc. FCNCA Shares lost 6.09% last week after wedbush The analyst downgraded Outperform stock to Neutral and lowered the price target from $2,450 to $2,150.
- ServiceNow, Inc. NOW Shares fell 5.93% under pressure following the Justice Department's Carahsoft investigation.
Also read:
Photo via company
Market news and data provided by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.